Previous studies have shown that adaptation of tumor cells to VEN is characterized by different mechanisms resulting in functional loss of pro-apoptotic regulators like BAD, BAX, NOXA and PUMA or by a shift in dependency from BCL-2 to other anti-apoptotic proteins like MCL-1 [26, 41–50]. The gene discussed is MCL1; the disease is neoplasm.